Trial intelligence / Profile preview

ESAT6-CFP10 for TB Diagnosis Phase III

NCT02623556Phase 3Completed

Sponsor
Zhifei Biological
Start
Dec 2015
Primary completion
Mar 2018
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of C-Tb in Tuberculosis (TB), sponsored by Zhifei Biological. Started Dec 2015; status: completed.

02

Drugs

C-Tb
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT02623556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02623556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call